Abstract P195: Omacetaxine mepessucinate plus venetoclax show strong synergistic anti-leukemic activity in nucleophosmin ( NPM1 )-mutated AML patient-derived xenograft (PDX) models to support a phase 1 clinical trial
Mezzasoma, Federica, Cardinali, Valeria, Gionfriddo, Ilaria, Milano, Francesca, Sciabolacci, Sofia, Ferrari, Alessio, Sabino, Marcella, Silvestri, Serenella, Donini, Serena, Tini, Valentina, Spinozzi, Giulio, Falini, Brunangelo, Martelli, Maria Paola
Published in Molecular cancer therapeutics (01.12.2021)
Published in Molecular cancer therapeutics (01.12.2021)
Get full text
Journal Article